Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin for Iftar Glycemic Excursions in T1DM
NCT06021119Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2023
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in type 1 diabetes mellitus (T1D), sponsored by Ain Shams University. Started Mar 2023; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06021119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06021119.